Jump to content

Search results

  • Reports, the 2022 impact factor of the journal is 50.3. It is part of the Cell Press portfolio, which is owned by Elsevier. Issues are published monthly...
    15 KB (1,628 words) - 14:50, 4 August 2024
  • in 2021. Meanwhile, three additional Elsevier journals have joined the Cell Press group: Current Biology launched in January 1996, which became part of...
    8 KB (694 words) - 13:38, 17 June 2024
  • Thumbnail for Umifenovir
    anti-HIV drug Darunavir. A three-arm RCT study published in May 2020 in the Cell Press journal Clinical Advances found that neither Umifenovir or Lopinavir/Ritonavir...
    26 KB (2,266 words) - 07:11, 4 September 2024
  • Thumbnail for Vojo Deretic
    autophagy in immunity and inflammation: A more recent review by Deretic in the Cell Press journal Immunity summarizes the role of autophagy in inflammation and...
    37 KB (3,926 words) - 00:47, 12 June 2024